Health of Special Immigrant Visa holders from Iraq and Afghanistan after arrival into the United States using Domestic Medical Examination data, 2014–2016: A cross-sectional analysis
Autoři:
Gayathri S. Kumar aff001; Clelia Pezzi aff001; Simone Wien aff001; Blain Mamo aff002; Kevin Scott aff003; Colleen Payton aff003; Kailey Urban aff002; Stephen Hughes aff004; Lori Kennedy aff005; Nuny Cabanting aff006; Jessica Montour aff007; Melissa Titus aff008; Jenny Aguirre aff009; Breanna Kawasaki aff005; Rebecca Ford aff010; Emily S. Jentes aff001
Působiště autorů:
Centers for Disease Control and Prevention, Division of Global Migration and Quarantine, Immigrant, Refugee, and Migrant Health Branch, Atlanta, Georgia, United States of America
aff001; Minnesota Department of Health, Saint Paul, Minnesota, United States of America
aff002; Thomas Jefferson University, Philadelphia, Pennsylvania, United States of America
aff003; Bureau of Tuberculosis Control, New York State Department of Health, Albany, New York, United States of America
aff004; Colorado Department of Public Health and Environment, Disease Control and Environmental Epidemiology Division, Refugee Health Program, Denver, Colorado, United States of America
aff005; Office of Refugee Health, Center for Infectious Diseases, California Department of Public Health, Sacramento, California, United States of America
aff006; Texas Department of State Health Services, Austin, Texas, United States of America
aff007; Marion County Public Health Department, Indianapolis, Indiana, United States of America
aff008; Illinois Department of Public Health, Refugee Health Program, Chicago, Illinois, United States of America
aff009; University of Louisville Division of Infectious Diseases, Louisville, Kentucky, United States of America
aff010
Vyšlo v časopise:
Health of Special Immigrant Visa holders from Iraq and Afghanistan after arrival into the United States using Domestic Medical Examination data, 2014–2016: A cross-sectional analysis. PLoS Med 17(3): e32767. doi:10.1371/journal.pmed.1003083
Kategorie:
Research Article
doi:
https://doi.org/10.1371/journal.pmed.1003083
Souhrn
Background
Since 2008, the United States has issued between 2,000 and 19,000 Special Immigrant Visas (SIV) annually, with the majority issued to applicants from Iraq and Afghanistan. SIV holders (SIVH) are applicants who were employed by, or on behalf of, the US government or the US military. There is limited information about health conditions in SIV populations to help guide US clinicians caring for SIVH. Thus, we sought to describe health characteristics of recently arrived SIVH from Iraq and Afghanistan who were seen for domestic medical examinations.
Methods and findings
This cross-sectional analysis included data from Iraqi and Afghan SIVH who received a domestic medical examination from January 2014 to December 2016. Data were gathered from state refugee health programs in seven states (California, Colorado, Illinois, Kentucky, Minnesota, New York, and Texas), one county, and one academic medical center and included 6,124 adults and 4,814 children. Data were collected for communicable diseases commonly screened for during the exam, including tuberculosis (TB), hepatitis B, hepatitis C, malaria, strongyloidiasis, schistosomiasis, other intestinal parasites, syphilis, gonorrhea, chlamydia, and human immunodeficiency virus, as well as elevated blood lead levels (EBLL). We investigated the frequency and proportion of diseases and whether there were any differences in selected disease prevalence in SIVH from Iraq compared to SIVH from Afghanistan. A majority of SIV adults were male (Iraqi 54.0%, Afghan 58.6%) and aged 18–44 (Iraqi 86.0%, Afghan 97.7%). More SIV children were male (Iraqi 56.2%, Afghan 52.2%) and aged 6–17 (Iraqi 50.2%, Afghan 40.7%). The average age of adults was 29.7 years, and the average age for children was 5.6 years. Among SIV adults, 14.4% were diagnosed with latent tuberculosis infection (LTBI), 63.5% were susceptible to hepatitis B virus (HBV) infection, and 31.0% had at least one intestinal parasite. Afghan adults were more likely to have LTBI (prevalence ratio [PR]: 2.0; 95% confidence interval [CI] 1.5–2.7) and to be infected with HBV (PR: 4.6; 95% CI 3.6–6.0) than Iraqi adults. Among SIV children, 26.7% were susceptible to HBV infection, 22.1% had at least one intestinal parasite, and 50.1% had EBLL (≥5 mcg/dL). Afghan children were more likely to have a pathogenic intestinal parasite (PR: 2.7; 95% CI 2.4–3.2) and EBLL (PR: 2.0; 95% CI 1.5–2.5) than Iraqi children. Limitations of the analysis included lack of uniform health screening data collection across all nine sites and possible misclassification by clinicians of Iraqi and Afghan SIVH as Iraqi and Afghan refugees, respectively.
Conclusion
In this analysis, we observed that 14% of SIV adults had LTBI, 27% of SIVH had at least one intestinal parasite, and about half of SIV children had EBLL. Most adults were susceptible to HBV. In general, prevalence of infection was higher for most conditions among Afghan SIVH compared to Iraqi SIVH. The Centers for Disease Control and Prevention (CDC) Guidelines for the US Domestic Medical Examination for Newly Arriving Refugees can assist state public health departments and clinicians in the care of SIVH during the domestic medical examination. Future analyses can explore other aspects of health among resettled SIV populations, including noncommunicable diseases and vaccination coverage.
Klíčová slova:
Hepatitis B – Hepatitis B virus – Intestinal parasites – Screening guidelines – SIV – Tuberculosis – Vaccination and immunization – Iraq
Zdroje
1. US Department of State, Bureau of Population, Refugees, and Migration, Office of Admissions, Refugee Processing Center. Admissions & Arrivals, SIV Arrivals by Nationality by Month. [cited 2019 Mar 22]. Available from: https://www.wrapsnet.org/admissions-and-arrivals/.
2. US Department of State, Bureau of Consular Affairs. Directory of Visa Categories. [cited 2019 May 21]. Available from: https://travel.state.gov/content/travel/en/us-visas/visa-information-resources/all-visa-categories.html.
3. US Department of Health and Human Services, Centers for Disease Control and Prevention (CDC). Technical Instructions for Panel Physicians. [cited 2019 Apr 2019]. Available from: https://www.cdc.gov/immigrantrefugeehealth/exams/ti/panel/technical-instructions-panel-physicians.html.
4. US Department of State, Bureau of Population, Refugees, and Migration. SIV Refugee Benefits Election Form 2017 (English). [cited 2019 May 21]. Available from: https://www.wrapsnet.org/siv-iraqi-syrian-p-2/.
5. US Department of Health and Human Services, Office of the Administration for Children & Families, Office of Refugee Resettlement. Health Insurance. [cited 2019 May 21]. Available from: https://www.acf.hhs.gov/orr/health.
6. US Department of Health and Human Services, Office of Refugee Resettlement. Revised Medical Screening Guidelines for Newly Arriving Refugees. [cited 2019 May 21]. Available from: http://www.acf.hhs.gov/sites/default/files/orr/state_letter_12_09_revised_medical_screening_guidelines_for_newly.pdf.
7. US Department of Health and Human Services, CDC. Vaccination Technical Instructions for Panel Physicians. [cited 2019 Feb 20]. Available from: https://www.cdc.gov/immigrantrefugeehealth/exams/ti/panel/vaccination-panel-technical-instructions.html.
8. US Department of Health and Human Services, CDC. Health of resettled Iraqi refugees–San Diego County, California, October 2007–September 2009. MMWR Morb Mortal Wkly Rep. 2010;59:1614–1618. 21160458
9. Yanni EA, Naoum M, Odeh N, Han P, Coleman M, Burke H. The health profile and chronic diseases comorbidities of US-bound Iraqi refugees screened by the International Organization for Migration in Jordan: 2007–2009. J Immigr Minor Health. 2013;15:1–9. doi: 10.1007/s10903-012-9578-6 22307545
10. Yun K, Matheson J, Payton C, Scott KC, Stone BL, Song L, et al. Health profiles of newly arrived refugee children in the United States, 2006–2012. Am J Public Health. 2016;106:128–135. doi: 10.2105/AJPH.2015.302873 26562126
11. Sanati Pour M, Kumble S, Hanieh S, Biggs B. Prevalence of dyslipidemia and micronutrient deficiencies among newly arrived Afghan refugees in rural Australia: a cross-sectional study. BMC Public Health. 2014;14:896. doi: 10.1186/1471-2458-14-896 25175525
12. Huetteman E. ‘They Will Kill Us’: Afghan Translators Plead for Delayed U.S. Visas. The New York Times. 2019 Aug 9. [cited 2019 Mar 19]. Available from: https://www.nytimes.com/2016/08/10/us/politics/afghan-translators-military-visas.html.
13. Al Jazeera. Afghan Translators: Out of Hiding. 2016 Nov 15. [cited 2019 Mar 19]. Available from: https://www.aljazeera.com/programmes/faultlines/2016/11/afghan-translators-hiding-161114104958282.html.
14. US Department of Health and Human Services, CDC. Guidelines for the US Domestic Medical Examination for Newly Arriving Refugees. [cited 2019 Feb 21]. Available from: http://www.cdc.gov/immigrantrefugeehealth/guidelines/domestic/domestic-guidelines.html.
15. American Thoracic Society. Diagnostic Standards and Classification of Tuberculosis in Adults and Children. Am J Respir Crit Care Med. 2000;161:1376–1395. doi: 10.1164/ajrccm.161.4.16141 10764337
16. Mitruka K, Pezzi C, Baack B, Burke H, Cochran J, Matheson J, et al. Evaluation of hepatitis B virus screening, vaccination, and linkage to care among newly arrived refugees in four states, 2009–2011. J Immigr Minor Health. 2019;21:39–46. doi: 10.1007/s10903-018-0705-x 29417356
17. US Department of Health and Human Services, CDC. Screening for Lead during the Domestic Medical Examination for Newly Arrived Refugees. [cited 2019 Nov 15]. Available from: https://www.cdc.gov/immigrantrefugeehealth/guidelines/lead-guidelines.html.
18. World Health Organization. Afghanistan: Tuberculosis profile. [cited 2019 Jul 29]. Available from: https://extranet.who.int/sree/Reports?op=Replet&name=/WHO_HQ_Reports/G2/PROD/EXT/TBCountryProfile&ISO2=AF&outtype=html.
19. World Health Organization. Iraq: Tuberculosis profile. [cited 2019 Jul 29]. Available from: https://extranet.who.int/sree/Reports?op=Replet&name=/WHO_HQ_Reports/G2/PROD/EXT/TBCountryProfile&ISO2=IQ&outtype=html.
20. US Department of Health and Human Services, CDC. Guidelines for Screening for Tuberculosis Infection and Disease during the Domestic Medical Examination for Newly Arrived Refugees. [cited 2019 Jul 31]. Available from: https://www.cdc.gov/immigrantrefugeehealth/guidelines/domestic/tuberculosis-guidelines.html.
21. Mixson-Hayden T, Lee D, Ganova-Raeva L, Drobeniuc J, Stauffer WM, Teshale E, et al. Hepatitis B virus and hepatitis C virus infections in United States-bound refugees from Asia and Africa. Am J Trop Med Hyg. 2014;90:1014–1020. doi: 10.4269/ajtmh.14-0068 24732462
22. Chironna M, Germinario C, Lopalco PL, Carrozzini F, Barbuti S, Quarto M. Prevalence rates of viral hepatitis infections in refugee Kurds from Iraq and Turkey. Infection. 2003;31:70–74. doi: 10.1007/s15010-002-3100-3 12682810
23. Richter C, Ter Beest G, Gisolf EH, Van Bentum P, Waegemaekers C, Swanink C, et al. Screening for chronic hepatitis B and C in migrants from Afghanistan, Iran, Iraq, the former Soviet Republics, and Vietnam in the Arnhem region, The Netherlands. Epidemiol Infect. 2014;142:2140–2146. doi: 10.1017/S0950268813003415 24398373
24. Scott KC, Taylor EM, Mamo B, Herr ND, Cronkright PJ, Yun K, et al. Hepatitis B screening and prevalence among resettled refugees—United States, 2006–2011. MMWR Morb Mortal Wkly Rep. 2015;64:570–573. 26042647
25. Khanani MR, Ansari AS, Kazmi SU, Ali SH. Concentrated epidemics of HIV, HCV, and HBV among Afghan refugees. J Infect. 2010; 61:434–437. doi: 10.1016/j.jinf.2010.08.009 20831883
26. Tanju IA, Levent F, Sezer RG, Cekmez F. Hepatitis B, hepatitis C, and human immunodeficiency virus seropositivity among children in Kabul, Afghanistan: A cross-sectional study. Hepat Mon. 2014;14(3):e16154. doi: 10.5812/hepatmon.16154 24693318
27. Nasir A, Todd CS, Stanekzi MR, Bautista CT, Botros BA, Scott PT, et al. Prevalence of HIV, hepatitis B and hepatitis C and associated risk behaviours amongst injecting drug users in three Afghan cities. Int J Drug Policy. 2011;22:145–152. doi: 10.1016/j.drugpo.2010.10.006 21146392
28. Khan S, Attaullah S. Share of Afghanistan populace in hepatitis B and hepatitis C infection’s pool: is it worthwhile? Virol J. 2011;8:216. doi: 10.1186/1743-422X-8-216 21569317
29. Todd CS, Abed AM, Strathdee SA, Scott PT, Botros BA, Safi N, et al. HIV, hepatitis C, and hepatitis B infections and associated risk behavior in injection drug users, Kabul Afghanistan. Emerg Infect Dis. 2007;13:1327–1331. doi: 10.3201/eid1309.070036 18252103
30. Todd CS, Nasir A, Stanekzai MR, Bautista CT, Botros BA, Scott PT, et al. HIV, hepatitis B, and hepatitis C prevalence and associated risk behaviors among female sex workers in three Afghan cities. AIDS. 2010;24(suppl 2):S69–S75.
31. Freidl GS, Tostmann A, Curvers M, Ruijs WLM, Smits G, Schepp R, et al. Immunity against measles, mumps, rubella, varicella, diphtheria, tetanus, polio, hepatitis A and hepatitis B among adult asylum seekers in the Netherlands, 2016. Vaccine. 2018;36:1664–1672. doi: 10.1016/j.vaccine.2018.01.079 29454516
32. Centers for Disease Control and Prevention. Vaccination Services in Postwar Iraq, May 2003. MMWR Morb Mortal Wkly Rep. 2003;52:734–735. 12904740
33. World Health Organization. Immunization, Vaccines and Biologicals: Data, statistics and graphics. [cited 2019 Mar 1]. Available from: https://www.who.int/immunization/monitoring_surveillance/data/en/.
34. Al-lela OQB, Bahari MB, Baderden SK, Basher AY, Hamoodi HK. Factors affecting on immunization compliance: Iraq. J Pharm Pract Community Med. 2017;3:246–253.
35. US Department of Health and Human Services, CDC. Vaccination Program for U.S.-Bound Refugees. [cited 2019 Mar 15]. Available from: https://www.cdc.gov/immigrantrefugeehealth/guidelines/overseas/interventions/immunizations-schedules.html.
36. US Department of Health and Human Services, CDC. Screening for Viral Hepatitis During the Domestic Medical Examination of Newly Arrived Refugees. [cited 2019 Jan 15]. Available from: https://www.cdc.gov/immigrantrefugeehealth/guidelines/domestic/hepatitis-screening-guidelines.html.
37. US Department of Health and Human Services, CDC. Evaluating and Updating Immunizations during the Domestic Medical Examination for Newly Arrived Refugees. [cited 2019 Feb 10]. Available from: https://www.cdc.gov/immigrantrefugeehealth/guidelines/domestic/immunizations-guidelines.html.
38. Mahdi NK, Ali NH. Intestinal parasites, including Cryptosporidium species, in Iraqi patients with sickle-cell anaemia. East Mediterr Health J. 2002;8:345–349. 15339123
39. Al-Saeed AT, Issa SH. Frequency of Giardia lamblia among children in Dohuk, northern Iraq. East Mediterr Health J. 2006;12:555–561. 17333793
40. Mahdi NK, Setrak SK, Shiwaish SM. Diagnostic methods for intestinal parasites in southern Iraq with reference to Strongyloides stercoralis. Southeast Asian J Trop Med Public Health. 1993;24:685–91. 7939941
41. Al-Kubaisy W, Al-Talib H, Al-khateeb A, Shanshal MM. Intestinal parasitic diarrhea among children in Baghdad—Iraq. Trop Biomed. 2014;31:499–506. 25382477
42. Korzeniewski K. Prevalence of intestinal parasitic infections in the population of Central Asia on the example of inhabitants of Eastern Afghanistan. Przegl Epidemiol. 2016;70:563–573. 28221011
43. Korzeniewski K, Smolen A, Augustynowicz A, Lass A. Diagnostics of intestinal parasites in light microscopy among the population of children in eastern Afghanistan. Ann Agric Environ Med. 2016;23:666–670. doi: 10.5604/12321966.1226864 28030941
44. Abrar Ul Haq K, Gul NA, Hammad HM, Bibi Y, Bibi A, Mohsan J. Prevalence of Giardia intestinalis and Hymenolepsis nana in Afghan refugee population of Mianwali district, Pakistan. Afr Health Sci. 2015;15:394–400. doi: 10.4314/ahs.v15i2.12 26124784
45. Duda A, Kosik-Bogacka D, Lanocha-Arendarczyk N, Kolodziejczyk L, Lanocha A. The prevalence of Blastocystis hominis and other protozoan parasites in soldiers returning from peacekeeping missions. Am J Trop Med Hyg. 2015;92:805–806. doi: 10.4269/ajtmh.14-0344 25732683
46. US Department of Health and Human Services, CDC. Domestic Intestinal Parasite Guidelines. [cited 2019 Feb 10]. Available from: https://www.cdc.gov/immigrantrefugeehealth/guidelines/domestic/intestinal-parasites-domestic.html.
47. US Department of Health and Human Services, CDC. Screening for Sexually Transmitted Diseases during the Domestic Medical Examination for Newly Arrived Refugees. [cited 2020 Jan 8]. Available from: https://www.cdc.gov/immigrantrefugeehealth/guidelines/domestic/sexually-transmitted-diseases/index.html
48. US Department of Health and Human Services, CDC. Infant lead poisoning associated with use of tiro, an eye cosmetic from Nigeria—Boston, Massachusetts, 2011. MMWR Morb Mortal Wkly Rep. 2012;61:574–576. 22854626
49. US Department of Health and Human Services, CDC. Childhood lead exposure associated with the use of kajal, an eye cosmetic from Afghanistan—Albuquerque, New Mexico, 2013. MMWR Morb Mortal Wkly Rep. 2013;62:917–919. 24257200
50. McMichael JR, Stoff BK. Surma eye cosmetic in Afghanistan: a potential source of lead toxicity in children. Eur J Pediatr. 2018;177:265–268. doi: 10.1007/s00431-017-3056-z 29224187
51. Pezzi C, Lee D, Kennedy L, Aguirre J, Titus M, Ford R, et al. Blood Lead Levels Among Resettled Refugee Children in Select US States, 2010–2014. Pediatrics. 2019;143(5). Epub 2019/04/19. doi: 10.1542/peds.2018-2591 30996119.
Článek vyšel v časopise
PLOS Medicine
2020 Číslo 3
- Případ Bulovka: Jak postupují jiné nemocnice, aby podobným tragédiím zabránily?
- Jak často se u masových střelců vyskytují duševní choroby?
- FDA varuje před selfmonitoringem cukru pomocí chytrých hodinek. Jak je to v Česku?
- Metamizol jako analgetikum první volby: kdy, pro koho, jak a proč?
- Není statin jako statin aneb praktický přehled rozdílů jednotlivých molekul
Nejčtenější v tomto čísle
- Dietary fibre and whole grains in diabetes management: Systematic review and meta-analyses
- An Integrative Adapt Therapy for common mental health symptoms and adaptive stress amongst Rohingya, Chin, and Kachin refugees living in Malaysia: A randomized controlled trial
- Fecal microbiota transplantation for the improvement of metabolism in obesity: The FMT-TRIM double-blind placebo-controlled pilot trial
- Safety, tolerability, and immunogenicity of influenza vaccination with a high-density microarray patch: Results from a randomized, controlled phase I clinical trial